Premium BsAb announced a production approach that uses LC-MS-assisted analytics and chain-ratio optimization to generate bispecific antibodies with more than 98% heterodimer purity across multiple formats. The offering combines high-titer CHO expression with LC-MS-assisted purification workflows aimed at reducing mispairing and low-yield outcomes that can complicate bsAb development.